A 503A compounding pharmacy operates under section 503A of the federal Food, Drug, and Cosmetic Act, compounding individualized prescriptions in response to a patient-specific order from a licensed prescriber. REVRCEL works exclusively with licensed compounding pharmacies; every REVRCEL prescription is compounded patient-specifically against a named prescription, never as office stock.
Related terms
Statements have not been evaluated by the FDA. Educational content only; not medical advice.
